Patents, licences and trademarks |
up to 20 years |
Technology |
up to 13 years |
Customer relationships |
up to 15 years |
Software |
up to seven years |
shorter of the economic life and the period the right is |
|
Patents and intellectual property |
legally enforceable |
Freehold and long leasehold buildings | 2% per annum |
Short leasehold property | over the period of the lease |
Plant, machinery, etc. | 10% to 20% per annum |
Fixtures, fittings, tools and other equipment | 10% to 33% per annum |
Year ended 31 July 2025 | |||||
Smiths | Corporate | ||||
John Crane | Flex-Tek | Detection | costs | Total | |
£m | £m | £m | £m | £m | |
Revenue | 1,115 | 837 | 963 | – | 2,915 |
Segmental headline operating profit | 265 | 164 | 122 | – | 551 |
Corporate headline operating costs | – | – | – | (46) | (46) |
Headline operating profit/(loss) | 265 | 164 | 122 | (46) | 505 |
Items excluded from headline measures | |||||
(note 3) | (1) | (45) | (26) | (23) | (95) |
Operating profit/(loss) | 264 | 119 | 96 | (69) | 410 |
Headline operating margin | 23.8% | 19.5% | 12.7% | 17.3% |
Year ended 31 July 2024 – represented* | |||||
Smiths | Corporate | ||||
John Crane | Flex-Tek | Detection | costs | Total | |
£m | £m | £m | £m | £m | |
Revenue | 1,133 | 786 | 859 | – | 2,778 |
Segmental headline operating profit | 263 | 161 | 102 | – | 526 |
Corporate headline operating costs | – | – | – | (49) | (49) |
Headline operating profit/(loss) | 263 | 161 | 102 | (49) | 477 |
Items excluded from headline measures | |||||
(note 3) | (34) | (26) | (19) | (29) | (108) |
Operating profit/(loss) | 229 | 135 | 83 | (78) | 369 |
Headline operating margin | 23.2% | 20.5% | 11.9% | 17.1% |
Year ended 31 July 2025 | |||||
Smiths | Corporate and | ||||
John Crane | Flex-Tek | Detection | non-headline | Total | |
£m | £m | £m | £m | £m | |
Depreciation – property, plant and equipment | 16 | 9 | 10 | 3 | 38 |
Depreciation – right of use assets | 14 | 7 | 9 | 1 | 31 |
Amortisation – capitalised development costs | – | – | 10 | – | 10 |
Amortisation of software, patents and | |||||
intellectual property | 4 | – | 9 | 1 | 14 |
Amortisation of acquired intangibles | – | – | – | 50 | 50 |
Restructuring costs | – | – | – | 22 | 22 |
Impairment – prior year working capital | – | – | – | 15 | 15 |
Share-based payment | 4 | 3 | 3 | 8 | 18 |
Year ended 31 July 2024 – represented* | |||||
Smiths | Corporate and | ||||
John Crane | Flex-Tek | Detection | non-headline | Total | |
£m | £m | £m | £m | £m | |
Depreciation – property, plant and equipment | 17 | 9 | 11 | – | 37 |
Depreciation – right of use assets | 15 | 7 | 8 | 1 | 31 |
Amortisation – capitalised development costs | – | – | 2 | – | 2 |
Amortisation of software, patents and | |||||
intellectual property | 1 | – | 1 | 1 | 3 |
Amortisation of acquired intangibles | – | – | – | 47 | 47 |
Share-based payment | 3 | 2 | 2 | 5 | 12 |
31 July 2025 | |||||
Smiths | Corporate and | ||||
John Crane | Flex-Tek | Detection | non-headline | Total | |
£m | £m | £m | £m | £m | |
Property, plant, equipment, right of use | |||||
assets, development projects, other | |||||
intangibles and investments | 185 | 113 | 132 | 11 | 441 |
Inventory, trade and other receivables | 518 | 251 | 622 | 22 | 1,413 |
Segment assets | 703 | 364 | 754 | 33 | 1,854 |
31 July 2024 | ||||||
Smiths | Smiths | Corporate and | ||||
John Crane | Flex-Tek | Detection | Interconnect | non-headline | Total | |
£m | £m | £m | £m | £m | £m | |
Property, plant, equipment, | ||||||
right of use assets, development | ||||||
projects, other intangibles and | ||||||
investments | 168 | 103 | 153 | 65 | 61 | 550 |
Inventory, trade and other | ||||||
receivables | 528 | 254 | 612 | 153 | 18 | 1,565 |
Segment assets | 696 | 357 | 765 | 218 | 79 | 2,115 |
31 July 2025 | |||||
Smiths | Corporate and | ||||
John Crane | Flex-Tek | Detection | non-headline | Total | |
£m | £m | £m | £m | £m | |
Segmental liabilities | 173 | 105 | 374 | – | 652 |
Corporate and non-headline liabilities | – | – | – | 319 | 319 |
Segment liabilities | 173 | 105 | 374 | 319 | 971 |
31 July 2024 | ||||||
Smiths | Smiths | Corporate and | ||||
John Crane | Flex-Tek | Detection | Interconnect | non-headline | Total | |
£m | £m | £m | £m | £m | £m | |
Segmental liabilities | 202 | 99 | 398 | 59 | – | 758 |
Corporate and non-headline | ||||||
liabilities | – | – | – | – | 341 | 341 |
Segment liabilities | 202 | 99 | 398 | 59 | 341 | 1,099 |
Assets | Liabilities | |||
31 July | 31 July | 31 July | 31 July | |
2025 | 2024 | 2025 | 2024 | |
£m | £m | £m | £m | |
Segment assets and liabilities | 1,854 | 2,115 | (971) | (1,099) |
Goodwill and acquired intangibles | 1,192 | 1,404 | – | – |
Derivatives | 17 | 4 | (2) | (17) |
Current and deferred tax | 118 | 118 | (109) | (102) |
Retirement benefit assets and obligations | 128 | 132 | (96) | (103) |
Cash and borrowings | 195 | 459 | (667) | (659) |
Assets and liabilities held for sale | 507 | – | (106) | – |
Statutory assets and liabilities | 4,011 | 4,232 | (1,951) | (1,980) |
Smiths | Corporate and | ||||
John Crane | Flex-Tek | Detection | non-headline | Total | |
£m | £m | £m | £m | £m | |
Capital expenditure year ended 31 July 2025 | 41 | 13 | 13 | – | 67 |
Capital expenditure year ended 31 July 2024 | 34 | 10 | 28 | 3 | 75 |
31 July 2025 | ||||
Smiths | ||||
John Crane | Flex-Tek | Detection | Total | |
£m | £m | £m | £m | |
Average segmental capital employed | 1,051 | 689 | 1,079 | 2,819 |
Average capital employed – assets held for sale | 447 | |||
Average corporate capital employed | (62) | |||
Average total capital employed – continuing operations | 3,204 |
31 July 2024 | ||||
Smiths | ||||
John Crane | Flex-Tek | Detection | Total | |
£m | £m | £m | £m | |
Average segmental capital employed | 1,035 | 606 | 1,124 | 2,765 |
Average capital employed – assets held for sale | 472 | |||
Average corporate capital employed | (31) | |||
Average total capital employed – continuing operations | 3,206 |
Original | |||
equipment | Aftermarket | Total | |
John Crane | £m | £m | £m |
Revenue year ended 31 July 2025 | 322 | 793 | 1,115 |
Revenue year ended 31 July 2024 | 321 | 812 | 1,133 |
Aerospace | Industrials | Total | |
Flex-Tek | £m | £m | £m |
Revenue year ended 31 July 2025 | 159 | 678 | 837 |
Revenue year ended 31 July 2024 | 154 | 632 | 786 |
Other detection | |||
Aviation | systems | Total | |
Smiths Detection | £m | £m | £m |
Revenue year ended 31 July 2025 | 715 | 248 | 963 |
Revenue year ended 31 July 2024 | 595 | 264 | 859 |
General | Safety & | Aerospace | |||
Industrial | Security | Energy | & Defence | Total | |
£m | £m | £m | £m | £m | |
John Crane revenue | |||||
Revenue year ended 31 July 2025 | 413 | – | 702 | – | 1,115 |
Revenue year ended 31 July 2024 | 407 | – | 726 | – | 1,133 |
Flex-Tek revenue | |||||
Revenue year ended 31 July 2025 | 678 | – | – | 159 | 837 |
Revenue year ended 31 July 2024 | 632 | – | – | 154 | 786 |
Smiths Detection revenue | |||||
Revenue year ended 31 July 2025 | – | 963 | – | – | 963 |
Revenue year ended 31 July 2024 | – | 859 | – | – | 859 |
Total revenue | |||||
Revenue year ended 31 July 2025 | 1,091 | 963 | 702 | 159 | 2,915 |
Revenue year ended 31 July 2024 – | |||||
represented* | 1,039 | 859 | 726 | 154 | 2,778 |
Year ended | ||
Year ended | 31 July 2024 | |
31 July 2025 | represented* | |
£m | £m | |
Sale of goods recognised at a point in time | 2,080 | 1,962 |
Sale of goods recognised over time | 10 | 11 |
Services recognised over time | 825 | 805 |
2,915 | 2,778 |
Americas | Europe | Asia Pacific | Rest of World | Total | |
£m | £m | £m | £m | £m | |
Revenue year ended 31 July 2025 | 1,616 | 529 | 435 | 335 | 2,915 |
Revenue year ended 31 July 2024 – | |||||
represented | 1,494 | 541 | 421 | 322 | 2,778 |
31 July 2025 – non-current operating assets by geographical location: | |||||
Intangible assets | 794 | 476 | 14 | – | 1,284 |
Property, plant and equipment | 140 | 61 | 23 | 20 | 244 |
Right of use assets | 51 | 33 | 10 | 5 | 99 |
Other receivables | 56 | 22 | 1 | 5 | 84 |
Non-current operating assets | 1,041 | 592 | 48 | 30 | 1,711 |
31 July 2024 represented* – non-current operating assets by geographical location: | |||||
Intangible assets | 1,045 | 462 | 14 | – | 1,521 |
Property, plant and equipment | 162 | 63 | 29 | 16 | 270 |
Right of use assets | 55 | 38 | 12 | 5 | 110 |
Other receivables | 56 | 17 | – | 14 | 87 |
Non-current operating assets - restated | 1,318 | 580 | 55 | 35 | 1,988 |
Year ended 31 July 2025 | Year ended 31 July 2024 – represented* | |||||
Non-headline | Non-headline | |||||
Headline | (note 3) | Total | Headline | (note 3) | Total | |
£m | £m | £m | £m | £m | £m | |
Cost of sales – direct materials, | ||||||
labour, production and | ||||||
distribution overheads | 1,839 | – | 1,839 | 1,742 | – | 1,742 |
Selling costs | 194 | – | 194 | 200 | – | 200 |
Administrative expenses | 379 | 95 | 474 | 361 | 108 | 469 |
Research and development tax | ||||||
credits | (2) | – | (2) | (2) | – | (2) |
Total | 2,410 | 95 | 2,505 | 2,301 | 108 | 2,409 |
Year ended | ||
Year ended | 31 July 2024 | |
31 July 2025 | represented* | |
£m | £m | |
Research, development and customer-specific engineering expense | 96 | 94 |
Depreciation of property, plant and equipment | 38 | 37 |
Depreciation of right of use assets | 31 | 31 |
Amortisation of intangible assets | 74 | 53 |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Audit services | ||
Fees payable to the Company’s auditors for the audit of the Company’s | ||
annual financial statements | 2.5 | 2.8 |
Fees payable to the Company’s auditors and its associates for other | ||
services: | ||
– the audit of the Company’s subsidiaries | 3.5 | 3.6 |
6.0 | 6.4 | |
Audit related assurance services (i) | 2.1 | 0.4 |
Other assurance services (ii) | 0.2 | 0.1 |
Total fees | 8.3 | 6.9 |
Year ended | |||
Year ended | 31 July 2024 | ||
31 July 2025 | represented* | ||
Notes | £m | £m | |
Acquisition and disposal related costs | |||
Detection separation costs | (10) | – | |
Post-acquisition integration costs and fair value adjustment unwind | (4) | (3) | |
Fair value movement on contingent consideration | 4 | (13) | |
Loss on disposal of financial asset | (3) | (9) | |
Business acquisition costs and related expenses | (2) | (4) | |
Legacy pension scheme arrangements | |||
Scheme administration costs | 8 | (4) | (6) |
Past service costs for benefit equalisation | 8 | – | (4) |
Non-headline provision movements | |||
Environmental remediation provision | (2) | – | |
Provision held against Titeflex Corporation subrogation claims | 23 | 5 | 5 |
Provision for John Crane, Inc. asbestos litigation | 23 | 12 | (29) |
Cost recovery for John Crane, Inc. asbestos litigation | 1 | 3 | |
Other items | |||
Corporate restructuring costs | (22) | – | |
Impairment of prior year working capital balances | (15) | – | |
Cyber incident remediation costs | (4) | – | |
Amortisation of acquired intangible assets | 10 | (50) | (47) |
Funding of charitable foundation | (1) | (1) | |
Non-headline items in operating profit – continuing operations | (95) | (108) |
Year ended | |||
Year ended | 31 July 2024 | ||
31 July 2025 | represented | ||
Notes | £m | £m | |
Unwind of discount on provisions | 23 | (9) | (9) |
Unwind of discount on other payables | (1) | – | |
Other finance income – retirement benefits | 8 | 3 | 6 |
Release of interest payment on overdue VAT | 4 | – | |
Other sundry financing losses | (1) | (2) | |
Non-headline items in finance costs – continuing operations | (4) | (5) | |
Continuing operations – non-headline loss before taxation | (99) | (113) |
Year ended | |||
Year ended | 31 July 2024 | ||
31 July 2025 | represented | ||
Notes | £m | £m | |
Tax credit on non-headline loss | 6 | 23 | 23 |
Increase in unrecognised UK deferred tax asset | 6 | (3) | (19) |
Non-headline taxation credit – continuing operations | 20 | 4 | |
Continuing operations – non-headline loss for the year | (79) | (109) |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
Notes | £m | £m |
Impairment loss on reclassification to held for sale | (30) | – |
Interconnect separation costs | (8) | – |
Amortisation of acquisition related intangible assets | (2) | (2) |
Business acquisition costs and related expenses | – | (1) |
Tax on non-headline loss | (1) | (3) |
Non-headline items in profit – discontinued operations | (41) | (6) |
Loss for the year – non headline items for continuing and | ||
discontinued operations | (120) | (115) |
Year ended | |||
Year ended | 31 July 2024 | ||
31 July 2025 | represented* | ||
Notes | £m | £m | |
Interest income | 40 | 26 | |
Interest expense: | |||
– bank loans and overdrafts, including associated fees | (52) | (46) | |
– other loans | (12) | (12) | |
– interest on leases | (6) | (5) | |
– interest on uncertain tax provisions | (1) | – | |
Interest expense | (71) | (63) | |
Headline net finance costs | (31) | (37) | |
Other financing (losses)/gains: | |||
– valuation movements on fair value hedged debt | (13) | 5 | |
– valuation movements on fair value derivatives | 15 | (5) | |
– foreign exchange and ineffectiveness on net | |||
investment hedges | (3) | (2) | |
– unwind of discount on provisions and other payables | 3 | (10) | (9) |
Other financing losses | (11) | (11) | |
Other non-headline finance cost items: | |||
– release of interest payment on overdue VAT | 4 | – | |
– other finance income – Interest on retirement benefits | 8 | 3 | 6 |
Other non-headline finance cost items | 7 | 6 | |
Net finance costs | (35) | (42) |
Year ended | ||
Year ended | 31 July 2024 | |
31 July 2025 | represented* | |
£m | £m | |
Profit attributable to equity shareholders for the year: | ||
– continuing | 274 | 221 |
– discontinued | 16 | 29 |
Total | 290 | 250 |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
Number of shares | Number of shares | |
Number of shares in issue, net of shares held in Employee Benefit Trust: | ||
Weighted average number for basic earnings per share | 338,390,299 | 345,901,957 |
Adjustment for potentially dilutive shares | 1,576,039 | 1,389,223 |
Weighted average number for diluted earnings per share | 339,966,338 | 347,291,180 |
Year ended | ||
Year ended | 31 July 2024 | |
31 July 2025 | represented | |
pence | pence | |
Statutory earnings per share total – basic | 85.7p | 72.3p |
Statutory earnings per share total – diluted | 85.3p | 72.0p |
Statutory earnings per share continuing operations – basic | 81.0p | 63.9p |
Statutory earnings per share continuing operations – diluted | 80.6p | 63.7p |
Year ended 31 July 2025 | Year ended 31 July 2024 represented | |||||
Basic EPS | Diluted EPS | Basic EPS | Diluted EPS | |||
£m | (p) | (p) | £m | (p) | (p) | |
Total profit attributable to equity | ||||||
shareholders of the Parent Company | 290 | 85.7p | 85.3p | 250 | 72.3p | 72.0p |
Exclude: Non-headline items (note 3) | 120 | 115 | ||||
Headline earnings per share | 410 | 121.2p | 120.6p | 365 | 105.5p | 105.2p |
Profit from continuing operations | ||||||
attributable to equity shareholders of the | ||||||
Parent Company | 274 | 81.0p | 80.6p | 221 | 63.9p | 63.7p |
Exclude: Non-headline items (note 3) | 79 | 109 | ||||
Headline earnings per share – | ||||||
continuing operations | 353 | 104.3p | 103.8p | 330 | 95.4p | 95.1p |
Year ended | ||
Year ended | 31 July 2024 | |
31 July 2025 | represented* | |
£m | £m | |
The taxation charge in the consolidated income statement for the year comprises: | ||
Continuing operations | ||
Current taxation: | ||
– current income tax charge | 98 | 101 |
– current tax adjustments in respect of prior periods | – | 2 |
Current taxation | 98 | 103 |
Deferred taxation | 1 | 2 |
Total taxation expense – continuing operations | 99 | 105 |
Discontinued operations | ||
Current taxation: | ||
– current income tax charge | 19 | 12 |
– deferred taxation | – | 4 |
Total taxation expense – discontinued operations | 19 | 16 |
Analysed as: | ||
Headline taxation expense | 137 | 122 |
Non-headline taxation credit | (19) | (1) |
Total taxation expense in the consolidated income statement | 118 | 121 |
Year ended Year ended | ||
31 July 2025 | 31 July 2024 | |
£m | £m | |
Tax on items credited to equity | ||
Deferred tax: | ||
– share based payments | (1) | – |
– retirement benefit schemes | – | (17) |
Taxation on retirement benefit movements | (1) | (17) |
Current tax | |
£m | |
At 31 July 2023 | (30) |
Charge to income statement | (115) |
Tax paid | 99 |
At 31 July 2024 | (46) |
Comprising: | |
Current tax receivable | 24 |
Current tax payable within one year | (70) |
At 31 July 2024 | (46) |
Charge to income statement – continuing operations | (98) |
Charge to income statement – discontinued operations | (19) |
Tax paid | 113 |
Transfer to held for sale | 4 |
At 31 July 2025 | (46) |
Comprising: | |
Current tax receivable | 20 |
Current tax payable within one year | (66) |
At 31 July 2025 | (46) |
Year ended | ||
Year ended | 31 July 2024 | |
31 July 2025 | represented* | |
£m | £m | |
Profit before taxation | 375 | 327 |
Notional taxation expense at UK corporate rate of 25.0% (FY2024: 25%) | 94 | 82 |
Different tax rates on non-UK profits and losses | (6) | (5) |
Non-deductible expenses and other charges | 21 | 19 |
Tax credits and non-taxable income | (10) | (6) |
Non-headline UK deferred tax asset recognition adjustment | 3 | 19 |
Other adjustments to unrecognised deferred tax | (5) | (6) |
Prior year true-up | 2 | 2 |
Taxation on continuing operations | 99 | 105 |
Taxation on discontinued operations | 19 | 16 |
Total taxation expense in the consolidated income statement | 118 | 121 |
Comprising: | ||
Taxation on headline profit | 119 | 109 |
Non-headline taxation items: | ||
– Tax credit on non-headline loss | (23) | (23) |
– UK deferred tax asset recognition adjustment | 3 | 19 |
Taxation on non-headline items | (20) | (4) |
Taxation on discontinued operations | 19 | 16 |
Total taxation expense in the consolidated income statement | 118 | 121 |
Property, plant, | ||||||
equipment and | Losses | |||||
intangible | Employment | carried | ||||
assets | benefits | forward | Provisions | Other | Total | |
£m | £m | £m | £m | £m | £m | |
At 31 July 2023 | (86) | (25) | 75 | 66 | 22 | 52 |
Reallocations | (9) | (1) | 5 | – | 5 | – |
Charge to income statement – | ||||||
continuing operations | 16 | (2) | (15) | 4 | (9) | (6) |
Charge to income statement – | ||||||
discontinued operations | ||||||
Credit to equity | – | 17 | – | – | – | 17 |
Foreign exchange rate | ||||||
movements | – | (1) | – | 1 | (1) | (1) |
At 31 July 2024 | (79) | (12) | 65 | 71 | 17 | 62 |
Comprising: | ||||||
Deferred tax assets | (9) | (15) | 31 | 63 | 24 | 94 |
Deferred tax liabilities | (70) | 3 | 34 | 8 | (7) | (32) |
At 31 July 2024 | (79) | (12) | 65 | 71 | 17 | 62 |
Reallocations | 6 | – | (4) | 4 | (6) | – |
Charge to income statement – | ||||||
continuing operations | 5 | (1) | (3) | (6) | 4 | (1) |
Credit to equity | – | 1 | – | – | – | 1 |
Acquisitions in the year | (9) | – | – | – | – | (9) |
Foreign exchange rate | ||||||
movements | 1 | – | (1) | (3) | – | (3) |
Transfer to held for sale | 18 | – | (9) | (2) | (2) | 5 |
At 31 July 2025 | (58) | (12) | 48 | 64 | 13 | 55 |
Comprising: | ||||||
Deferred tax assets | (12) | (15) | 28 | 60 | 37 | 98 |
Deferred tax liabilities | (46) | 3 | 20 | 4 | (24) | (43) |
At 31 July 2025 | (58) | (12) | 48 | 64 | 13 | 55 |
2025 | Expiry of | 2024 | Expiry of | |
£m | losses | £m | losses | |
Unrestricted losses – operating losses | 572 | No expiry | 603 | No expiry |
Year ended 31 July 2025 | Year ended 31 July 2024 represented* | |||||
Continuing | Discontinued | Continuing | Discontinued | |||
Operations | Operations | Total | Operations | Operations | Total | |
£m | £m | £m | £m | £m | £m | |
Staff costs during the period | ||||||
Wages and salaries | 751 | 114 | 865 | 743 | 101 | 844 |
Social security | 90 | 16 | 106 | 85 | 14 | 99 |
Share-based payment (note 9) | 19 | 2 | 21 | 13 | 1 | 14 |
Pension costs (including defined | ||||||
contribution schemes) (note 8) | 33 | 2 | 35 | 33 | 2 | 35 |
Total | 893 | 134 | 1,027 | 874 | 118 | 992 |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
John Crane | 6,250 | 6,200 |
Flex-Tek | 4,200 | 4,050 |
Smiths Detection | 3,500 | 3,400 |
Smiths Interconnect | 2,650 | 2,600 |
Corporate (including central/shared IT services) | 350 | 300 |
Total | 16,950 | 16,550 |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Key management compensation | ||
Salaries and short-term employee benefits | 16.3 | 12.6 |
Cost of retirement benefits | 0.6 | 0.7 |
Cost of share-based incentive plans | 9.4 | 3.4 |
Year ended 31 July 2025 | Year ended 31 July 2024 | |||
Weighted | Weighted | |||
Number of | average | Number of | average | |
instruments | exercise | instruments | exercise | |
’000 | price | ’000 | price | |
LTIP | 1,375 | 1,389 | ||
SAYE | 10 | £13.09 | 11 | £13.06 |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
£m | £m | |
At beginning of period | 29 | 89 |
Foreign exchange rate movements | – | 1 |
Current service cost | (2) | (4) |
Headline scheme administration costs | (2) | (3) |
Non-headline scheme administration costs | (4) | (6) |
Past service cost, curtailments, settlements – continuing operations | – | (4) |
Finance income – retirement benefits | 3 | 6 |
Contributions by employer | 11 | 16 |
Actuarial losses | (3) | (66) |
Net retirement benefit asset | 32 | 29 |
The critical estimates and principal assumptions used in updating the valuations are set out below: | ||||||
2025 | 2025 | 2025 | 2024 | 2024 | 2024 | |
UK | US | Other | UK | US | Other | |
Rate of increase in salaries | n/a | n/a | 0.2% | n/a | n/a | 2.8% |
Rate of increase for active deferred | ||||||
members | 4.1% | n/a | n/a | 4.0% | n/a | n/a |
Rate of increase in pensions in payment | 3.1% | n/a | 1.8% | 3.3% | n/a | 0.5% |
Rate of increase in deferred pensions | 3.1% | n/a | n/a | 3.3% | n/a | n/a |
Discount rate | 5.6% | 5.5% | 2.6% | 5.0% | 5.2% | 2.8% |
Inflation rate | 3.1% | n/a | 0.9% | 3.3% | n/a | 2.1% |
UK schemes | ||||
Male | Female | Male | Female | |
31 July 2025 | 31 July 2025 | 31 July 2024 | 31 July 2024 | |
Member who retires next year at age 65 | 22 | 24 | 22 | 24 |
Member, currently 45, when they retire in 20 years’ time | 23 | 25 | 23 | 25 |
US schemes | ||||
Male | Female | Male | Female | |
Expected further years of life | 31 July 2025 | 31 July 2025 | 31 July 2024 | 31 July 2024 |
Member who retires next year at age 65 | 21 | 22 | 21 | 22 |
Member, currently 45, when they retire in 20 years’ time | 22 | 24 | 22 | 24 |
Profit before | Increase/ | (Increase)/ | Profit before | Increase/ | (Increase)/ | |
tax | (decrease) in | decrease in | tax | (decrease) in | decrease in | |
for year | scheme | scheme | for year | scheme | scheme | |
ended | assets | liabilities | ended | assets | liabilities | |
31 July 2025 | 31 July 2025 | 31 July 2025 | 31 July 2024 | 31 July 2024 | 31 July 2024 | |
£m | £m | £m | £m | £m | £m | |
Rate of mortality – one year | ||||||
increase in life expectancy | (2) | 53 | (90) | (2) | 66 | (108) |
Rate of mortality – one year | ||||||
decrease in life expectancy | 2 | (55) | 93 | 2 | (67) | 110 |
Rate of inflation – 0.25% increase | (1) | 19 | (37) | (1) | 21 | (39) |
Discount rate – 0.25% increase | 2 | (28) | 56 | 2 | (33) | 65 |
Market value of scheme assets – | ||||||
2.5% increase | 2 | 28 | – | 2 | 30 | – |
31 July 2025 – £m | ||||
UK | US | Other | ||
schemes | schemes | countries | Total | |
Cash and cash equivalents | 30 | 20 | 1 | 51 |
Pooled funds: | ||||
– Pooled equity | – | 21 | 5 | 26 |
– Pooled Diversified Growth | – | – | 13 | 13 |
– Pooled credit | 340 | – | – | 340 |
Corporate bonds | 131 | 50 | – | 181 |
Government bonds/LDI | 436 | 89 | 3 | 528 |
Insured liabilities | 1,199 | – | – | 1,199 |
Total market value | 2,136 | 180 | 22 | 2,338 |
31 July 2024 – £m | ||||
UK | US | Other | ||
schemes | schemes | countries | Total | |
Cash and cash equivalents | 63 | 8 | 1 | 72 |
Pooled funds: | ||||
– Pooled equity | – | – | 5 | 5 |
– Pooled Diversified Growth | – | – | 12 | 12 |
– Pooled credit | 337 | – | – | 337 |
Corporate bonds | 208 | 141 | – | 349 |
Government bonds/LDI | 427 | 41 | 3 | 471 |
Insured liabilities | 1,337 | – | – | 1,337 |
Total market value | 2,372 | 190 | 21 | 2,583 |
31 July 2025 – £m | |||
US | |||
SIPS | TIGPS | schemes | |
Present value of funded scheme liabilities: | |||
– Active deferred members | (12) | (8) | (26) |
– Deferred members | (332) | (260) | (71) |
– Pensioners | (841) | (544) | (91) |
Present value of funded scheme liabilities | (1,185) | (812) | (188) |
Market value of scheme assets | 1,313 | 823 | 180 |
Surplus restriction | – | (11) | – |
Surplus/(deficit) | 128 | – | (8) |
31 July 2024 – £m | |||
US | |||
SIPS | TIGPS | schemes | |
Present value of funded scheme liabilities: | |||
– Active deferred members | (13) | (9) | (28) |
– Deferred members | (379) | (304) | (80) |
– Pensioners | (915) | (609) | (93) |
Present value of funded scheme liabilities | (1,307) | (922) | (201) |
Market value of scheme assets | 1,439 | 933 | 190 |
Surplus restriction | – | (11) | – |
Surplus/(deficit) | 132 | – | (11) |
31 July 2025 – £m | ||||
UK | US | Other | ||
schemes | schemes | countries | Total | |
Market value of scheme assets | 2,136 | 180 | 22 | 2,338 |
Present value of funded scheme liabilities | (1,997) | (188) | (28) | (2,213) |
Surplus restriction | (11) | (11) | ||
Surplus/(deficit) | 128 | (8) | (6) | 114 |
Unfunded pension plans | (33) | (5) | (41) | (79) |
Post-retirement healthcare | (2) | (1) | – | (3) |
Present value of unfunded obligations | (35) | (6) | (41) | (82) |
Net pension asset/(liability) | 93 | (14) | (47) | 32 |
Comprising: | ||||
Retirement benefit assets | 128 | – | – | 128 |
Retirement benefit liabilities | (35) | (14) | (47) | (96) |
Net pension asset/(liability) | 93 | (14) | (47) | 32 |
31 July 2024 – £m | ||||
UK | US | Other | ||
schemes | schemes | countries | Total | |
Market value of scheme assets | 2,372 | 190 | 21 | 2,583 |
Present value of funded scheme liabilities | (2,229) | (201) | (26) | (2,456) |
Surplus restriction | (11) | – | – | (11) |
Surplus/(deficit) | 132 | (11) | (5) | 116 |
Unfunded pension plans | (37) | (6) | (38) | (81) |
Post-retirement healthcare | (2) | (1) | (3) | (6) |
Present value of unfunded obligations | (39) | (7) | (41) | (87) |
Net pension asset/(liability) | 93 | (18) | (46) | 29 |
Comprising: | ||||
Retirement benefit assets | 132 | – | – | 132 |
Retirement benefit liabilities | (39) | (18) | (46) | (103) |
Net pension asset/(liability) | 93 | (18) | (46) | 29 |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Amounts charged to operating profit | ||
Current service cost | 2 | 4 |
Past service costs – benefit equalisations | – | 4 |
Headline scheme administration costs | 2 | 3 |
Non-headline scheme administration costs | 4 | 6 |
8 | 17 | |
The operating cost is charged as follows: | ||
Headline administrative expenses | 4 | 7 |
Non-headline administrative expenses | 4 | 10 |
8 | 17 | |
Amounts credited to finance costs | ||
Non-headline other finance income – retirement benefits | (3) | (6) |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Re-measurements of retirement defined benefit assets and liabilities | ||
Difference between interest credit and return on assets | (197) | 54 |
Experience gains/(losses) on scheme liabilities | 25 | (103) |
Actuarial gains arising from changes in demographic assumptions | – | 4 |
Actuarial gains/(losses) arising from changes in financial assumptions | 169 | (26) |
Movement in surplus restriction | – | 5 |
(3) | (66) |
31 July 2025 – £m | ||||
UK | US | Other | ||
schemes | schemes | countries | Total | |
At beginning of period | 2,372 | 190 | 21 | 2,583 |
Foreign exchange rate movements | – | (6) | – | (6) |
Interest on assets | 115 | 9 | 1 | 125 |
Actuarial movement on scheme assets | (192) | (6) | 1 | (197) |
Employer contributions | – | 5 | – | 5 |
Scheme administration costs | (5) | (1) | – | (6) |
Benefits paid | (154) | (11) | (1) | (166) |
At end of period | 2,136 | 180 | 22 | 2,338 |
31 July 2024 – £m | ||||
UK | US | Other | ||
schemes | schemes | countries | Total | |
At beginning of period | 2,367 | 186 | 20 | 2,573 |
Interest on assets | 117 | 9 | 1 | 127 |
Actuarial movement on scheme assets | 54 | (1) | 1 | 54 |
Employer contributions | – | 10 | – | 10 |
Scheme administration costs | (7) | (2) | – | (9) |
Benefits paid | (159) | (12) | (1) | (172) |
At end of period | 2,372 | 190 | 21 | 2,583 |
31 July 2025 – £m | ||||
UK | US | Other | ||
schemes | schemes | countries | Total | |
At beginning of period | (2,229) | (201) | (26) | (2,456) |
Foreign exchange rate movements | – | 6 | – | 6 |
Past service costs | – | – | – | – |
Interest on obligations | (107) | (10) | (2) | (119) |
Actuarial movement on liabilities | 185 | 6 | (1) | 190 |
Benefits paid | 154 | 11 | 1 | 166 |
At end of period | (1,997) | (188) | (28) | (2,213) |
31 July 2024 – £m | ||||
UK | US | Other | ||
schemes | schemes | countries | Total | |
At beginning of period | (2,156) | (202) | (25) | (2,383) |
Foreign exchange rate movements | – | – | 1 | 1 |
Past service costs | (3) | – | (1) | (4) |
Interest on obligations | (106) | (11) | (1) | (118) |
Actuarial movement on liabilities | (123) | – | (1) | (124) |
Benefits paid | 159 | 12 | 1 | 172 |
At end of period | (2,229) | (201) | (26) | (2,456) |
Assets | Obligations | |||
Year ended | Year ended | Year ended | Year ended | |
31 July 2025 | 31 July 2024 | 31 July 2025 | 31 July 2024 | |
£m | £m | £m | £m | |
At beginning of period | – | – | (87) | (85) |
Current service cost | – | – | (2) | (4) |
Interest on obligations | – | – | (3) | (3) |
Actuarial movement | – | – | 4 | (1) |
Employer contributions | 6 | 6 | – | – |
Benefits paid | (6) | (6) | 6 | 6 |
At end of period | – | – | (82) | (87) |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Irrecoverable asset at beginning of period | (11) | (16) |
Actuarial movement on scheme assets | – | 5 |
At end of period | (11) | (11) |
Ordinary shares under option/ | Long-term | Restricted | Save as you earn | Weighted average | |
award (’000) | incentive plans | stock | scheme | Total | exercise price |
31 July 2023 | 4,828 | 87 | 958 | 5,873 | £1.78 |
Granted | 1,919 | 45 | 243 | 2,207 | £1.34 |
Exercised | (1,140) | (10) | (437) | (1,587) | £2.54 |
Lapsed | (1,218) | (8) | (79) | (1,305) | £0.73 |
31 July 2024 | 4,389 | 114 | 685 | 5,188 | £1.62 |
Granted | 1,909 | 132 | 184 | 2,225 | £1.06 |
Exercised | (968) | (52) | (100) | (1,120) | £1.03 |
Lapsed | (759) | – | (38) | (797) | £0.61 |
31 July 2025 | 4,571 | 194 | 731 | 5,496 | £1.65 |
Weighted average | Weighted average | |||
Total shares under | remaining | Total shares under | remaining | |
options/awards | contractual | options/awards | contractual | |
at 31 July 2025 | life at 31 July 2025 | at 31 July 2024 | life at 31 July 2024 | |
Range of exercise prices | (’000) | (months) | (’000) | (months) |
£0.00 – £2.00 | 4,765 | 17 | 4,503 | 17 |
£6.01 – £10.00 | – | – | 2 | – |
£10.01 – £12.00 | 731 | 26 | 683 | 29 |
Acquired | Software, | ||||
intangibles | patents and | ||||
Development | (see table | intellectual | |||
Goodwill | costs | below) | property | Total | |
£m | £m | £m | £m | £m | |
Cost | |||||
At 31 July 2023 | 1,273 | 193 | 612 | 159 | 2,237 |
Foreign exchange rate movements | (7) | (2) | (1) | – | (10) |
Business combinations | 10 | – | 34 | – | 44 |
Additions | – | 14 | – | 4 | 18 |
Disposals | – | – | – | (1) | (1) |
At 31 July 2024 | 1,276 | 205 | 645 | 162 | 2,288 |
Foreign exchange rate movements | (16) | – | (17) | (2) | (35) |
Business combinations | 77 | – | 59 | – | 136 |
Additions | – | 5 | – | 3 | 8 |
Disposals | – | – | – | (5) | (5) |
Reclassified to assets held for sale | (282) | – | (98) | (24) | (404) |
At 31 July 2025 | 1,055 | 210 | 589 | 134 | 1,988 |
Amortisation and impairments | |||||
At 31 July 2023 | 64 | 124 | 406 | 122 | 716 |
Foreign exchange rate movements | – | (2) | (2) | – | (4) |
Amortisation charge for the year | – | 2 | 49 | 5 | 56 |
Disposals | – | – | – | (1) | (1) |
At 31 July 2024 | 64 | 124 | 453 | 126 | 767 |
Foreign exchange rate movements | – | – | (10) | (1) | (11) |
Amortisation charge for the year | – | 10 | 52 | 15 | 77 |
Impairment charge for the year | – | – | – | 1 | 1 |
Disposals | – | – | – | (4) | (4) |
Reclassified to assets held for sale | (25) | – | (82) | (19) | (126) |
At 31 July 2025 | 39 | 134 | 413 | 118 | 704 |
Net book value at 31 July 2025 | 1,016 | 76 | 176 | 16 | 1,284 |
Net book value at 31 July 2024 | 1,212 | 81 | 192 | 36 | 1,521 |
Net book value at 31 July 2023 | 1,209 | 69 | 206 | 37 | 1,521 |
Patents, | ||||
licences | Total | |||
and | Customer | acquired | ||
trademarks | Technology | relationships | intangibles | |
£m | £m | £m | £m | |
Cost | ||||
At 31 July 2023 | 20 | 145 | 447 | 612 |
Foreign exchange rate movements | – | – | (1) | (1) |
Business combinations | 3 | – | 31 | 34 |
At 31 July 2024 | 23 | 145 | 477 | 645 |
Foreign exchange rate movements | (1) | (4) | (12) | (17) |
Business combinations | 12 | – | 47 | 59 |
Reclassified to assets held for sale | (3) | (39) | (56) | (98) |
At 31 July 2025 | 31 | 102 | 456 | 589 |
Amortisation | ||||
At 31 July 2023 | 9 | 92 | 305 | 406 |
Foreign exchange rate movements | – | – | (2) | (2) |
Charge for the year | 2 | 10 | 37 | 49 |
At 31 July 2024 | 11 | 102 | 340 | 453 |
Foreign exchange rate movements | – | (3) | (7) | (10) |
Charge for the year | 4 | 11 | 37 | 52 |
Reclassified to assets held for sale | (3) | (33) | (46) | (82) |
At July 2025 | 12 | 77 | 324 | 413 |
Net book value at 31 July 2025 | 19 | 25 | 132 | 176 |
Net book value at 31 July 2024 | 12 | 43 | 137 | 192 |
Net book value at 31 July 2023 | 11 | 53 | 142 | 206 |
2025 | 2024 | |||
2025 | Number of | 2024 | Number of | |
£m | CGUs | £m | CGUs | |
John Crane | 130 | 1 | 130 | 1 |
Flex-Tek | 263 | 1 | 193 | 1 |
Smiths Detection | 623 | 1 | 625 | 1 |
Smiths Interconnect – reclassified to assets held for sale | ||||
at 31 July 2025 (note 28) | – | 1 | 264 | 1 |
1,016 | 4 | 1,212 | 4 |
As at 31 May 2025 | |||||
Smiths | Smiths | ||||
John Crane | Flex-Tek | Detection | Interconnect | ||
Net book value of goodwill (£m) | 128 | 255 | 610 | 252 | |
Basis of valuation | Value in use | Value in use | Value in use | Value in use | |
Discount rate | – pre-tax | 11.8% | 13.6% | 12.8% | 12.7% |
– post-tax | 9.4% | 10.7% | 9.7% | 10.3% | |
Period covered by management projections | 5 years | 5 years | 5 years | 5 years | |
Capital expenditure – annual average over projection | |||||
period (£m) | 29 | 11 | 14 | 11 | |
Revenue – compound annual growth rate (CAGR) | |||||
over projection period | 6.4% | 3.5% | 4.6% | 6.2% | |
Average earnings before interest and tax margin | 25.7% | 21.4% | 13.3% | 21.1% | |
Long-term growth rates | 2.6% | 2.1% | 2.1% | 2.3% | |
As at 31 May 2024 | |||||
Smiths | Smiths | ||||
John Crane | Flex-Tek | Detection | Interconnect | ||
Net book value of goodwill (£m) | 135 | 191 | 649 | 279 | |
Basis of valuation | Value in use | Value in use | Value in use | Value in use | |
Discount rate | – pre-tax | 11.9% | 12.6% | 12.8% | 12.5% |
– post-tax | 9.4% | 10.0% | 9.5% | 10.1% | |
Period covered by management projections | 5 years | 5 years | 5 years | 5 years | |
Capital expenditure – annual average over projection | |||||
period (£m) | 31 | 10 | 19 | 12 | |
Revenue – CAGR over projection period | 6.1% | 3.6% | 3.8% | 4.4% | |
Average earnings before interest and tax margin | 22.2% | 20.5% | 12.9% | 15.8% | |
Long-term growth rates | 2.6% | 2.1% | 2.3% | 2.5% |
Change required for carrying value to equal recoverable amount | FY2025 | FY2024 |
Revenue – CAGR over five-year projection period | -940 bps decrease | -470 bps decrease |
Average earnings before interest and tax margin | -400 bps decrease | -220 bps decrease |
Post-tax discount rate | +340 bps increase | +150 bps increase |
Fixtures, | ||||
fittings, | ||||
Land and | Plant and | tools and | ||
buildings | machinery | equipment | Total | |
£m | £m | £m | £m | |
Cost or valuation | ||||
At 31 July 2023 | 178 | 463 | 120 | 761 |
Foreign exchange rate movements | (3) | (7) | (2) | (12) |
Business combinations | – | 7 | – | 7 |
Additions | 10 | 50 | 8 | 68 |
Disposals | (4) | (17) | (12) | (33) |
At 31 July 2024 | 181 | 496 | 114 | 791 |
Foreign exchange rate movements | (3) | (8) | – | (11) |
Business combinations | – | 5 | – | 5 |
Additions | 6 | 60 | 6 | 72 |
Disposals | (5) | (22) | (7) | (34) |
Reclassified to assets held for sale | (8) | (101) | (26) | (135) |
At 31 July 2025 | 171 | 430 | 87 | 688 |
Depreciation | ||||
At 31 July 2023 | 110 | 302 | 102 | 514 |
Foreign exchange rate movements | (1) | (3) | (1) | (5) |
Charge for the year | 8 | 32 | 5 | 45 |
Disposals | (4) | (17) | (12) | (33) |
At 31 July 2024 | 113 | 314 | 94 | 521 |
Foreign exchange rate movements | (2) | (5) | – | (7) |
Charge for the year | 9 | 31 | 5 | 45 |
Disposals | (4) | (21) | (7) | (32) |
Impairment charge for the year | 3 | 6 | 1 | 10 |
Reclassified to assets held for sale | (8) | (63) | (22) | (93) |
At July 2025 | 111 | 262 | 71 | 444 |
Net book value at 31 July 2025 | 60 | 168 | 16 | 244 |
Net book value at 31 July 2024 | 68 | 182 | 20 | 270 |
Net book value at 31 July 2023 | 68 | 161 | 18 | 247 |
Properties | Vehicles | Equipment | Total | |
£m | £m | £m | £m | |
Cost or valuation | ||||
At 31 July 2023 | 190 | 27 | 2 | 219 |
Foreign exchange rate movements | (3) | (1) | – | (4) |
Business combinations | 12 | – | – | 12 |
Recognition of right of use asset | 18 | 10 | – | 28 |
Derecognition of right of use asset | (5) | – | – | (5) |
At 31 July 2024 | 212 | 36 | 2 | 250 |
Foreign exchange rate movements | (5) | – | – | (5) |
Business combinations | 6 | – | – | 6 |
Recognition of right of use asset | 23 | 5 | – | 28 |
Derecognition of right of use asset | (42) | (18) | (1) | (61) |
Reclassified to assets held for sale | (23) | – | – | (23) |
At 31 July 2025 | 171 | 23 | 1 | 195 |
Depreciation | ||||
At 31 July 2023 | 94 | 19 | 1 | 114 |
Foreign exchange rate movements | (2) | (1) | – | (3) |
Charge for the year | 29 | 5 | – | 34 |
Derecognition of right of use asset | (5) | – | – | (5) |
At 31 July 2024 | 116 | 23 | 1 | 140 |
Foreign exchange rate movements | (2) | – | – | (2) |
Charge for the year | 28 | 6 | – | 34 |
Derecognition of right of use asset | (42) | (18) | (1) | (61) |
Impairment charge for the year | 2 | – | – | 2 |
Reclassified to assets held for sale | (17) | – | – | (17) |
At 31 July 2025 | 85 | 11 | – | 96 |
Net book value at 31 July 2025 | 86 | 12 | 1 | 99 |
Net book value at 31 July 2024 | 96 | 13 | 1 | 110 |
Net book value at 31 July 2023 | 96 | 8 | 1 | 105 |
Investment in | Deferred | Investments | Cash | ||
ICU Medical, | contingent | in early stage | collateral | ||
Inc equity | consideration | businesses | deposit | Total | |
£m | £m | £m | £m | £m | |
Cost or valuation | |||||
At 31 July 2023 | 347 | 13 | 7 | 4 | 371 |
Fair value change through profit and loss | – | (13) | – | – | (13) |
Fair value change through other | |||||
comprehensive income | (103) | – | (2) | – | (105) |
Disposals | (197) | – | – | (3) | (200) |
At 31 July 2024 | 47 | – | 5 | 1 | 53 |
Fair value change through profit and loss | – | – | – | – | – |
Fair value change through other | |||||
comprehensive income | 8 | – | – | – | 8 |
Disposals | (55) | – | – | – | (55) |
At 31 July 2025 | – | – | 5 | 1 | 6 |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Raw materials and consumables | 133 | 192 |
Work in progress | 140 | 148 |
Finished goods | 313 | 303 |
Total inventories | 586 | 643 |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Gross inventory carried at full value | 505 | 560 |
Gross value of inventory partly or fully provided for | 138 | 146 |
643 | 706 | |
Inventory provision | (57) | (63) |
Inventory after provisions | 586 | 643 |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Non-current | ||
Trade receivables | 3 | – |
Prepayments | – | 1 |
Contract assets | 82 | 86 |
Other receivables | 5 | 9 |
90 | 96 | |
Current | ||
Trade receivables | 504 | 544 |
Prepayments | 36 | 58 |
Contract assets | 114 | 123 |
Other receivables | 83 | 101 |
737 | 826 |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Trade receivables which are not yet due | 388 | 436 |
Trade receivables which are between 1-30 days overdue | 49 | 56 |
Trade receivables which are between 31-60 days overdue | 22 | 17 |
Trade receivables which are between 61-90 days overdue | 13 | 13 |
Trade receivables which are between 91-120 days overdue | 6 | 5 |
Trade receivables which are more than 120 days overdue | 44 | 46 |
522 | 573 | |
Expected credit loss allowance provision | (15) | (29) |
Trade receivables | 507 | 544 |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Brought forward loss allowance at the start of the period | 29 | 30 |
Exchange adjustments | – | 1 |
Increase in allowance recognised in the income statement | 8 | 4 |
Amounts written off or recovered during the year | (19) | (6) |
Amounts reclassed to discontinued operations | (3) | – |
Carried forward loss allowance at the end of the year | 15 | 29 |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Non-current | ||
Other payables | 12 | 15 |
Contract liabilities | 26 | 26 |
38 | 41 | |
Current | ||
Trade payables | 229 | 274 |
Other payables | 46 | 35 |
Other taxation and social security costs | 27 | 60 |
Accruals | 222 | 204 |
Contract liabilities | 155 | 191 |
679 | 764 |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Cash and cash equivalents | ||
Net cash and deposits | 195 | 459 |
Short-term borrowings | ||
Lease liabilities | (29) | (32) |
Interest accrual | (3) | (2) |
(32) | (34) | |
Long-term borrowings | ||
€650m 2.00% Eurobond 2027 | (556) | (534) |
Lease liabilities | (79) | (91) |
(635) | (625) | |
Borrowings/gross debt | (667) | (659) |
Derivatives managing interest rate risk and currency profile of the debt | 10 | (13) |
Net debt (excludes £21m of net cash in discontinued operations) | (462) | (213) |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Cash at bank and in hand | 102 | 123 |
Short-term deposits | 93 | 336 |
Cash and cash equivalents | 195 | 459 |
Non-current | Current | Current | Non-current | ||
assets | assets | liabilities | liabilities | Net balance | |
£m | £m | £m | £m | £m | |
Derivatives managing interest rate risk and | |||||
currency profile of the debt | 10 | – | – | – | 10 |
Foreign exchange forward contracts | – | 7 | (2) | – | 5 |
At 31 July 2025 | 10 | 7 | (2) | – | 15 |
Derivatives managing interest rate risk and | |||||
currency profile of the debt | – | – | – | (13) | (13) |
Foreign exchange forward contracts | – | 4 | (4) | – | – |
At 31 July 2024 | – | 4 | (4) | (13) | (13) |
Changes in net debt | |||||||
Interest rate | Changes in | Total | |||||
Cash | Other | and cross- | other financing | liabilities | |||
and cash | short-term | Long-term | currency | items: FX from financing | |||
equivalents | borrowings | borrowings | swaps | Net debt | contracts | activities | |
£m | £m | £m | £m | £m | £m | £m | |
At 31 July 2024 | 459 | (34) | (625) | (13) | (213) | – | (213) |
Foreign exchange | |||||||
gains/(losses) | (12) | 1 | (11) | – | (22) | – | (22) |
Net cash inflow | |||||||
from continuing | |||||||
operations | (221) | – | – | – | (221) | – | (221) |
Reclassified to | |||||||
asset/liability held | |||||||
for sale | (31) | 2 | 8 | – | (21) | – | (21) |
Lease payments | – | 41 | – | – | 41 | – | 41 |
Interest paid | – | 63 | – | – | 63 | – | 63 |
Interest expense | – | (71) | – | – | (71) | – | (71) |
Cash inflow from | |||||||
matured derivative | |||||||
contracts | – | – | – | – | 2 | 2 | |
Fair value | |||||||
movements | – | – | (7) | 23 | 16 | 3 | 19 |
Lease liabilities | |||||||
acquired | – | (1) | (5) | – | (6) | – | (6) |
Net movement | |||||||
from new leases | |||||||
and modifications | – | (28) | – | – | (28) | – | (28) |
Reclassifications | – | (5) | 5 | – | – | – | – |
At 31 July 2025 | 195 | (32) | (635) | 10 | (462) | 5 | (457) |
Changes in net debt | |||||||
Interest rate | Changes in | Total | |||||
Cash | Other | and cross- | other financing | liabilities | |||
and cash | short-term | Long-term | currency | items: FX from financing | |||
equivalents | borrowings | borrowings | swaps | Net debt | contracts | activities | |
£m | £m | £m | £m | £m | £m | £m | |
At 31 July 2023 | 285 | (29) | (625) | (18) | (387) | 3 | (384) |
Foreign exchange | |||||||
gains/(losses) | (14) | 1 | 10 | – | (3) | – | (3) |
Net cash inflow | |||||||
from continuing | |||||||
operations | 188 | – | – | – | 188 | – | 188 |
Lease payments | – | 39 | – | – | 39 | – | 39 |
Interest paid | – | 57 | – | – | 57 | – | 57 |
Interest expense* | – | (63) | – | – | (63) | – | (63) |
Cash inflow from | |||||||
matured derivative | |||||||
contracts | – | – | – | – | – | 5 | 5 |
Fair value | |||||||
movements | – | – | (9) | 5 | (4) | (8) | (12) |
Lease liabilities | |||||||
acquired | – | – | (12) | – | (12) | – | (12) |
Net movement | |||||||
from new leases | |||||||
and modifications | – | (28) | – | – | (28) | – | (28) |
Reclassifications | – | (11) | 11 | – | – | – | – |
At 31 July 2024 | 459 | (34) | (625) | (13) | (213) | – | (213) |
At 31 July 2025 | |||||
Sterling | US$ | Euro | Other | Total | |
£m | £m | £m | £m | £m | |
Financial assets and liabilities | |||||
Financial instruments included in trade and | |||||
other receivables | 30 | 395 | 176 | 143 | 744 |
Financial instruments included in trade and | |||||
other payables | (58) | (221) | (96) | (107) | (482) |
Cash and cash equivalents | 18 | 99 | 26 | 52 | 195 |
Borrowings not designated as net investment | |||||
hedges | (24) | (51) | (11) | (22) | (108) |
(34) | 222 | 95 | 66 | 349 | |
Exclude balances held in operations with the | |||||
same functional currency | 33 | (386) | (74) | 28 | (399) |
Exposure arising from intra-Group loans | – | 154 | (15) | (46) | 93 |
Future forward foreign exchange contract | |||||
cash-flows | (85) | (52) | 32 | 105 | – |
(86) | (62) | 38 | 153 | 43 |
At 31 July 2024 | |||||
Sterling | US$ | Euro | Other | Total | |
£m | £m | £m | £m | £m | |
Financial assets and liabilities | |||||
Financial instruments included in trade and | |||||
other receivables | 38 | 417 | 147 | 195 | 797 |
Financial instruments included in trade and | |||||
other payables | (45) | (222) | (117) | (111) | (495) |
Cash and cash equivalents | 139 | 222 | 19 | 79 | 459 |
Borrowings not designated as net investment | |||||
hedges | (26) | (61) | (14) | (22) | (123) |
106 | 356 | 35 | 141 | 638 | |
Exclude balances held in operations with the | |||||
same functional currency | (108) | (305) | (38) | (153) | (604) |
Exposure arising from intra-Group loans | – | 65 | 37 | (71) | 31 |
Future forward foreign exchange contract | |||||
cash-flows | 13 | (93) | 6 | 74 | – |
11 | 23 | 40 | (9) | 65 |
Impact on | Gain/(loss) | Impact on | Gain/(loss) | |
profit | recognised in | profit | recognised in | |
for the year | reserves | for the year | reserves | |
FY2025 | FY2025 | FY2024 | FY2024 | |
£m | £m | £m | £m | |
US dollar | 4 | 2 | 1 | 2 |
Euro | (1) | (2) | (1) | (3) |
Sterling | 3 | (2) | (2) | – |
Year ended | Year ended | ||
31 July 2025 | 31 July 2024 | ||
£m | £m | ||
Brought forward cash-flow hedge reserve at start of year | – | – | |
Foreign exchange forward contracts: | Net fair value gains on effective hedges | (2) | – |
Amount reclassified to income statement | |||
– finance costs | 3 | – | |
Carried forward cash-flow hedge reserve at end of year | 1 | – |
Changes in value | ||||||
Changes in value | of the hedging | |||||
of the hedged item | instrument | |||||
for calculating | for calculating | Cash-flow hedge | ||||
Financial | ineffectiveness | ineffectiveness | reserve | |||
Hedged item | Hedged exposure | Hedging instrument | year | £m | £m | £m |
FY2025 | (2) | 2 | (2) | |||
Sales and | Foreign | Foreign exchange | ||||
purchases | currency risk | contracts | FY2024 | – | – | – |
At 31 July 2025 | At 31 July 2024 | |||||
US$ | Euro | Total | US$ | Euro | Total | |
£m | £m | £m | £m | £m | £m | |
Loans designated as net | ||||||
investment hedges | – | (296) | (296) | – | (288) | (288) |
Cross-currency swap | (240) | – | (240) | (248) | – | (248) |
(240) | (296) | (536) | (248) | (288) | (536) |
Year ended | Year ended | ||
31 July 2025 | 31 July 2024 | ||
£m | £m | ||
Brought forward net investment hedge reserve at start of year | (191) | (196) | |
Cross-currency swaps | Net fair value gains on effective hedges | 7 | – |
Bonds | Net fair value gains on effective hedges | (7) | 5 |
Carried forward net investment hedge reserve at end of year | (191) | (191) |
Changes in value | ||||||
Changes in value | of the hedging | |||||
of the hedged item | instrument | |||||
for calculating | for calculating | Net investment | ||||
ineffectiveness | ineffectiveness | hedge reserve | ||||
Hedged item | Hedged exposure | Hedging instrument | Financial year | £m | £m | £m |
Overseas | Foreign | Bonds | FY2025 | 7 | (7) | (7) |
operation | currency risk | Cross-currency | FY2025 | (7) | 8 | 7 |
swaps | ||||||
– | ||||||
Overseas | Foreign | Bonds | FY2024 | (5) | 5 | – |
operation | currency risk |
Loss | Loss | |
recognised | recognised | |
in hedge | in hedge | |
reserve | reserve | |
31 July 2025 | 31 July 2024 | |
£m | £m | |
US dollar | 27 | 28 |
Euro | 33 | 32 |
As at 31 July 2025 | ||||
At fair value | Cash and | |||
through | cash | Fair value of | ||
profit or loss | equivalents | Borrowings | borrowings | |
£m | £m | £m | £m | |
Fixed interest | ||||
Less than one year | – | – | (32) | (32) |
Between one and five years | – | – | (353) | (352) |
Greater than five years | – | – | (27) | (27) |
Total fixed interest financial liabilities | – | – | (412) | (411) |
Floating rate interest financial assets/(liabilities) | 1 | 142 | (255) | (257) |
Total interest-bearing financial assets/(liabilities) | 1 | 142 | (667) | (668) |
Non-interest-bearing assets in the same category | – | 53 | – | – |
Total | 1 | 195 | (667) | (668) |
As at 31 July 2024 | ||||
At fair value | Cash and | |||
through profit | cash | Fair value of | ||
or loss | equivalents | Borrowings | borrowings | |
£m | £m | £m | £m | |
Fixed interest | ||||
Less than one year | – | – | (34) | (34) |
Between one and five years | – | – | (351) | (343) |
Greater than five years | – | – | (33) | (33) |
Total fixed interest financial liabilities | – | – | (418) | (410) |
Floating rate interest financial assets/(liabilities) | 1 | 393 | (241) | (244) |
Total interest-bearing financial assets/(liabilities) | 1 | 393 | (659) | (654) |
Non-interest-bearing assets in the same category | – | 66 | – | – |
Total | 1 | 459 | (659) | (654) |
Changes in value | ||||||||
Changes in value | of the hedging | Accumulated fair value | ||||||
of hedged item | instrument | Carrying amount | adjustments on hedged item | |||||
for calculating | for calculating | |||||||
ineffectiveness | ineffectiveness | Assets | Liabilities | Assets | Liabilities | |||
Hedged item | Hedged exposure | Financial year | £m | £m | £m | £m | £m | £m |
Fixed rate bonds (a) | Interest rate and currency rate risk | FY2025 | (7) | 8 | – | 251 | – | (5) |
Fixed rate bonds (a) | Interest rate and currency rate risk | FY2024 | (9) | 9 | – | 253 | – | (12) |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Cash in AAA liquidity funds | 76 | 196 |
Cash at banks with at least a AA- credit rating | 33 | 26 |
Cash at banks with all other A credit ratings | 79 | 185 |
Cash at other banks | 7 | 52 |
Investments in bank deposits | 1 | 1 |
Other investments | 5 | 5 |
Total | 201 | 465 |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Expiring between one and two years (FY2024: n/a) | 200 | – |
Expiring after more than four years (FY2024: four years) | 605 | 623 |
Total 805 | 623 |
As at 31 July 2025 | |||||
Contractual | Total | ||||
Fair value | Lease | interest | contractual | ||
Borrowings | adjustments | liabilities | payments | cash-flows | |
£m | £m | £m | £m | £m | |
Less than one year | (3) | – | (29) | (11) | (43) |
Between one and two years | (561) | 5 | (19) | (11) | (586) |
Between two and three years | – | – | (14) | – | (14) |
Between three and four years | – | – | (11) | – | (11) |
Between four and five years | – | – | (8) | – | (8) |
Greater than five years | – | – | (27) | – | (27) |
Total | (564) | 5 | (108) | (22) | (689) |
As at 31 July 2024 - represented* | |||||
Contractual | Total | ||||
Borrowings | Fair value | Lease | interest | contractual | |
represented* | adjustments | liabilities | payments | cash-flows | |
£m | £m | £m | £m | £m | |
Less than one year | (2) | – | (32) | (11) | (45) |
Between one and two years | – | – | (21) | (11) | (32) |
Between two and three years | (546) | 12 | (18) | (11) | (563) |
Between three and four years | – | – | (11) | – | (11) |
Between four and five years | – | – | (8) | – | (8) |
Greater than five years | – | – | (33) | – | (33) |
Total | (548) | 12 | (123) | (33) | (692) |
As at 31 July 2025 | |||
Net | |||
Receipts | Payments | cash-flow | |
£m | £m | £m | |
Assets | |||
Less than one year | 238 | (231) | 7 |
Greater than one year | 271 | (261) | 10 |
Liabilities | |||
Less than one year | 208 | (210) | (2) |
Greater than one year | 7 | (7) | – |
Total | 724 | (709) | 15 |
As at 31 July 2024 | |||
Net | |||
Receipts | Payments | cash-flow | |
£m | £m | £m | |
Assets | |||
Less than one year | 260 | (256) | 4 |
Greater than one year | 4 | (4) | – |
Liabilities | |||
Less than one year | 223 | (227) | (4) |
Greater than one year | 254 | (267) | (13) |
Total | 741 | (754) | (13) |
At 31 July 2025 | ||||
Contract or | Fair value | |||
underlying | ||||
nominal | ||||
amount | Assets | Liabilities | Net | |
£m | £m | £m | £m | |
Foreign exchange contracts (cash-flow hedges) | 103 | 2 | (1) | 1 |
Foreign exchange contracts (not hedge accounted) | 357 | 5 | (1) | 4 |
Total foreign exchange contracts | 460 | 7 | (2) | 5 |
Cross-currency swaps (fair value and net investment | ||||
hedges) | 240 | 10 | – | 10 |
Total financial derivatives | 700 | 17 | (2) | 15 |
Balance sheet entries: | ||||
Non-current | 258 | 10 | – | 10 |
Current | 442 | 7 | (2) | 5 |
Total financial derivatives | 700 | 17 | (2) | 15 |
At 31 July 2024 | ||||
Contract or | Fair value | |||
underlying | ||||
nominal | ||||
amount | Assets | Liabilities | Net | |
£m | £m | £m | £m | |
Foreign exchange contracts (cash-flow hedges) | 178 | 2 | (2) | – |
Foreign exchange contracts (not hedge accounted) | 315 | 2 | (2) | – |
Total foreign exchange contracts | 493 | 4 | (4) | – |
Cross-currency swaps (fair value and net investment | ||||
hedges) | 248 | – | (13) | (13) |
Total financial derivatives | 741 | 4 | (17) | (13) |
Balance sheet entries: | ||||
Non-current | 255 | – | (13) | (13) |
Current | 486 | 4 | (4) | – |
Total financial derivatives | 741 | 4 | (17) | (13) |
Assets | Liabilities | Assets | Liabilities | |
31 July 2025 | 31 July 2025 | 31 July 2024 | 31 July 2024 | |
£m | £m | £m | £m | |
Gross value of assets and liabilities | 17 | (2) | 4 | (17) |
Related assets and liabilities subject to master netting | ||||
agreements | (2) | 2 | (4) | 4 |
Net exposure | 15 | – | – | (13) |
Maturity at 31 July 2025 | Maturity at 31 July 2024 | |||||
Up to | Up to | |||||
Hedged exposure | Hedging instrument | one year | One to five years | one year | One to five years | |
Fair value hedges | ||||||
Interest rate/ | Cross-currency swaps (EUR:GBP) | – Notional amount (£m) | – | 254 | – | 254 |
foreign currency risk | – Historical average exchange rate | – | 0.845 | – | 0.845 | |
– Average spread over three-month BBP SONIA | – | 1.860% | – | 1.860% | ||
Net investment hedges | ||||||
Foreign currency risk | Cross-currency swaps (GBP:USD) | – Notional amount (£m) | – | 240 | – | 248 |
– Historical average exchange rate | – | 1.2534 | – | 1.2534 | ||
Cash-flow hedges | ||||||
Foreign currency risk | Foreign exchange contracts (USD:GBP) | – Notional amount (£m) | 29 | – | 41 | – |
– Average exchange rate | 1.3076 | – | 1.2593 | – | ||
Foreign exchange contracts (EUR:USD) | – Notional amount (£m) | 16 | – | 24 | – | |
– Average exchange rate | 0.8017 | – | 0.9277 | – | ||
Foreign exchange contracts (GBP:EUR) | – Notional amount (£m) | 15 | – | 66 | – | |
– Average exchange rate | 0.8729 | – | 0.8588 | – | ||
Foreign exchange contracts (CHF:EUR) | – Notional amount (£m) | 11 | 3 | – | – | |
– Average exchange rate | 0.9240 | 0.9049 | – | – | ||
Foreign exchange contracts (AED:EUR) | – Notional amount (£m) | 13 | – | – | – | |
– Average exchange rate | 4.0632 | – | – | – | ||
Foreign exchange contracts (CZK:GBP) | – Notional amount (£m) | 10 | – | 25 | – | |
– Average exchange rate | 29.4206 | – | 28.6952 | – | ||
Foreign exchange contracts (AUD:EUR) | – Notional amount (£m) | 4 | – | 9 | – | |
– Average exchange rate | 1.7473 | – | 1.6564 | – |
At fair value | Total | ||||||
Basis for | At amortised | through profit | At fair value | carrying | Total | ||
determining | cost | or loss | through OCI | value | fair value | ||
As at 31 July 2025 | Notes | fair value | £m | £m | £m | £m | £m |
Financial assets | |||||||
Other investments | 14 | A | – | 1 | – | 1 | 1 |
Other investments | 14 | F | – | – | 5 | 5 | 5 |
Cash and cash | |||||||
equivalents | 18 | B | 195 | – | – | 195 | 195 |
Trade and other financial | |||||||
receivables | B/C | 744 | – | – | 744 | 744 | |
Derivative financial | |||||||
instruments | 20 | C | – | 17 | – | 17 | 17 |
Total financial assets | 939 | 18 | 5 | 962 | 962 | ||
Financial liabilities | |||||||
Trade and other financial | |||||||
payables | B | (468) | (14) | – | (482) | (482) | |
Short-term borrowings | 18 | B/D | (3) | – | – | (3) | (3) |
Long-term borrowings | 18 | D | (556) | – | – | (556) | (557) |
Lease liabilities | 18 | E | (108) | – | – | (108) | (108) |
Derivative financial | |||||||
instruments | 20 | C | – | (2) | – | (2) | (2) |
Total financial liabilities | (1,135) | (16) | – | (1,151) | (1,152) |
At fair value Total | |||||||
Basis for | At amortised | through profit | At fair value | carrying | Total | ||
determining | cost | or loss | through OCI | value | fair value | ||
As at 31 July 2024 | Notes | fair value | £m | £m | £m | £m | £m |
Financial assets | |||||||
Other investments | 14 | A | – | 1 | 47 | 48 | 48 |
Other investments | 14 | F | – | – | 5 | 5 | 5 |
Cash and cash | |||||||
equivalents | 18 | B | 459 | – | – | 459 | 459 |
Trade and other financial | |||||||
receivables | B/C | 797 | – | – | 797 | 797 | |
Derivative financial | |||||||
instruments | 20 | C | – | 4 | – | 4 | 4 |
Total financial assets | 1,256 | 5 | 52 | 1,313 | 1,313 | ||
Financial liabilities | |||||||
Trade and other financial | |||||||
payables | B | (495) | – | – | (495) | (495) | |
Short-term borrowings | 18 | B/D | (2) | – | – | (2) | (2) |
Long-term borrowings | 18 | D | (534) | – | – | (534) | (529) |
Lease liabilities | 18 | E | (123) | – | – | (123) | (123) |
Derivative financial | |||||||
instruments | 20 | C | – | (17) | – | (17) | (17) |
Total financial liabilities | (1,154) | (17) | – | (1,171) | (1,166) |
Trading | Non-headline and legacy | Total | |||
John Crane, | Titeflex | ||||
Inc. | Corporation | ||||
litigation | litigation | Other | |||
£m | £m | £m | £m | £m | |
At 31 July 2023 | 8 | 204 | 41 | 33 | 286 |
Business combinations | 1 | – | – | – | 1 |
Provision charged | 12 | 29 | – | 5 | 46 |
Provision released | (2) | – | (5) | (5) | (12) |
Unwind of provision discount | – | 8 | 1 | – | 9 |
Utilisation | (6) | (21) | (1) | (8) | (36) |
At 31 July 2024 | 13 | 220 | 36 | 25 | 294 |
Comprising: | |||||
Current liabilities | 10 | 32 | 13 | 20 | 75 |
Non-current liabilities | 3 | 188 | 23 | 5 | 219 |
At 31 July 2024 | 13 | 220 | 36 | 25 | 294 |
Foreign exchange rate movements | – | (6) | (1) | – | (7) |
Provision charged | 16 | – | 1 | 8 | 25 |
Provision released | (4) | (12) | (6) | – | (22) |
Unwind of provision discount | – | 8 | 1 | – | 9 |
Utilisation | (5) | (19) | (5) | (15) | (44) |
Reclassified to liability held for sale | (1) | – | – | – | (1) |
At 31 July 2025 | 19 | 191 | 26 | 18 | 254 |
Comprising: | |||||
Current liabilities | 12 | 23 | 7 | 14 | 56 |
Non-current liabilities | 7 | 168 | 19 | 4 | 198 |
At 31 July 2025 | 19 | 191 | 26 | 18 | 254 |
Year ended | Year ended | Year ended | Year ended | Year ended | |
31 July 2025 | 31 July 2024 | 31 July 2023 | 31 July 2022 | 31 July 2021 | |
JCI claims experience | |||||
Claims against JCI that have been dismissed | 313,000 | 312,000 | 310,000 | 306,000 | 305,000 |
Claims JCI is currently a defendant in | 21,000 | 20,000 | 20,000 | 22,000 | 22,000 |
Cumulative final judgements, after appeals, | |||||
against JCI since 1979 | 157 | 156 | 154 | 149 | 149 |
Cumulative value of awards (US$m) | |||||
since 1979 | 192 | 191 | 190 | 175 | 175 |
Year ended | Year ended | Year ended | Year ended | Year ended | |
31 July 2025 | 31 July 2024 | 31 July 2023 | 31 July 2022 | 31 July 2021 | |
£m | £m | £m | £m | £m | |
John Crane, Inc. litigation provision | |||||
Gross provision | 231 | 261 | 246 | 258 | 220 |
Discount | (40) | (41) | (42) | (29) | (8) |
Discounted pre-tax provision | 191 | 220 | 204 | 229 | 212 |
Deferred tax | (46) | (54) | (51) | (57) | (54) |
Discounted post-tax provision | 145 | 166 | 153 | 172 | 158 |
Operating profit charge/(credit) | |||||
(Decreased)/Increased provisions for adverse | |||||
judgements and legal defence costs | (11) | 28 | 28 | 24 | 10 |
Change in US risk-free rates | (1) | 1 | (15) | (18) | (5) |
Subtotal – items charged to the provision | (12) | 29 | 13 | 6 | 5 |
Litigation management, legal fees in | |||||
connection with litigation against insurers | |||||
and defence strategy | – | – | 2 | 1 | 1 |
Recoveries from insurers | (1) | (3) | (7) | – | (9) |
Total operating profit (credit)/charge | (13) | 26 | 8 | 7 | (3) |
Cash-flow | |||||
Provision utilisation – legal defence costs and | |||||
adverse judgements | (18) | (21) | (32) | (21) | (13) |
Litigation management expense | – | – | (2) | (1) | – |
Recoveries from insurers | 1 | 3 | 7 | – | 9 |
Net cash outflow | (17) | (18) | (27) | (22) | (4) |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Gross provision | 56 | 69 |
Discount | (30) | (33) |
Discounted pre-tax provision | 26 | 36 |
Deferred tax | (6) | (9) |
Discounted post-tax provision | 20 | 27 |
Issued | |||
capital | Consideration | ||
Number of shares | £m | £m | |
Ordinary shares of 37.5p each | |||
Total share capital at 31 July 2023 | 349,302,990 | 131 | |
Share buybacks | (4,205,196) | (1) | (70) |
Total share capital at 31 July 2024 | 345,097,794 | 130 | |
Share buybacks | (15,413,491) | (6) | (303) |
Total share capital at 31 July 2025 | 329,684,303 | 124 |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Ordinary final dividend of 30.2p (FY2024: 28.70p) paid 22 November 2024 | 104 | 100 |
Ordinary interim dividend of 14.23p (FY2024: 13.55p) paid 14 May 2025 | 48 | 47 |
152 | 147 |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Net investment hedge reserve | (191) | (191) |
Deferred tax on net investment hedge reserve | 7 | 7 |
Cashflow hedge reserve | 1 | – |
Hedge reserve total | (183) | (184) |
Wattco | Modular Metal | Duc-Pac | Total | ||
£m | £m | £m | £m | ||
Non-current assets | – acquired intangible assets | 24 | 17 | 18 | 59 |
– plant and machinery | 1 | 2 | 2 | 5 | |
– right of use assets | 4 | 1 | 1 | 6 | |
Current assets | – inventory | 2 | 7 | 3 | 12 |
– trade and other receivables | 1 | – | – | 1 | |
– cash and cash equivalents | 2 | 6 | 1 | 9 | |
Current liabilities | – trade and other payables | (6) | (1) | (1) | (8) |
Non-current liabilities | – deferred tax | (6) | (3) | – | (9) |
– lease liability | (4) | (1) | (1) | (6) | |
Net assets acquired | 18 | 28 | 23 | 69 | |
Goodwill on current period acquisitions | 58 | 7 | 12 | 77 | |
Total | 76 | 35 | 35 | 146 | |
Cash paid during the period | 68 | 31 | 31 | 130 | |
Deferred/contingent consideration | 8 | 4 | 4 | 16 | |
Total consideration | 76 | 35 | 35 | 146 |
Year ended 31 July 2025 | Year ended 31 July 2024 | |||||
Non-headline | Non-headline | |||||
Headline | (note3) | Total | Headline | (note 3) | Total | |
£m | £m | £m | £m | £m | £m | |
Revenue | 421 | – | 421 | 354 | – | 354 |
Operating costs | (346) | (10) | (356) | (305) | (3) | (308) |
Impairment loss | – | (30) | (30) | – | – | – |
Operating profit/(loss) | 75 | (40) | 35 | 49 | (3) | 46 |
Finance costs | – | – | – | (1) | – | (1) |
Profit/(loss) before taxation | 75 | (40) | 35 | 48 | (3) | 45 |
Taxation | (18) | (1) | (19) | (13) | (3) | (16) |
Profit/(loss) from discontinued | ||||||
operations | 57 | (41) | 16 | 35 | (6) | 29 |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Net cash inflow from operating activities | 65 | 20 |
Net cash-flow used in investing activities | (13) | (11) |
Net cash-flow used in financing activities | (14) | (4) |
Net increase in cash and cash equivalents | 38 | 5 |
Total | |||
SII | Interconnect | 31 July 2025 | |
£m | £m | £m | |
Assets classified as held for sale: | |||
Intangible assets | – | 278 | 278 |
Property, plant and equipment | – | 43 | 43 |
Right of use assets | – | 6 | 6 |
Inventories | 9 | 65 | 74 |
Deferred tax assets | – | 1 | 1 |
Current tax receivable | – | 2 | 2 |
Trade and other receivables | 12 | 60 | 72 |
Cash and cash equivalents | – | 31 | 31 |
Assets classified as held for sale | 21 | 486 | 507 |
Liabilities classified as held for sale: | |||
Financial liabilities - leases | (4) | (6) | (10) |
Trade and other payables | (9) | (74) | (83) |
Current tax payable | – | (6) | (6) |
Deferred tax liabilities | (1) | (5) | (6) |
Provisions for liabilities and charges | – | (1) | (1) |
Liabilities classified as held for sale | (14) | (92) | (106) |
Americas | Europe | APAC | ROW | Total | |
£m | £m | £m | £m | £m | |
Revenue by geographical location | |||||
Revenue year ended 31 July 2025 | 214 | 76 | 116 | 15 | 421 |
Revenue year ended 31 July 2024 | 200 | 81 | 54 | 19 | 354 |
Year ended 31 July 2025 – Selected operating assets by geographical location | |||||
Intangible assets | 275 | 3 | – | – | 278 |
Property, plant and equipment | 26 | 11 | 6 | – | 43 |
Right of use asset | 5 | 1 | – | – | 6 |
Total | 306 | 15 | 6 | – | 327 |
Year ended 31 July 2025 | Year ended 31 July 2024 – represented* | |||||
Headline | Non-headline | Total | Headline | Non-headline | Total | |
£m | £m | £m | £m | £m | £m | |
Operating profit: | ||||||
– continuing operations | 505 | (95) | 410 | 477 | (108) | 369 |
– discontinued operations | 75 | (40) | 35 | 49 | (3) | 46 |
Amortisation of intangible assets | 25 | 52 | 77 | 7 | 49 | 56 |
Impairment on sale of SII | – | 30 | 30 | – | – | – |
Depreciation of property, plant | ||||||
and equipment | 43 | 2 | 45 | 44 | 1 | 45 |
Depreciation of right of use | ||||||
assets | 34 | – | 34 | 34 | – | 34 |
Loss on disposal of property, | ||||||
plant and equipment | 2 | – | 2 | 1 | – | 1 |
Loss on fair value of contingent | ||||||
consideration | – | – | – | – | 13 | 13 |
Share-based payment expense | 21 | – | 21 | 13 | – | 13 |
Retirement benefits** | 4 | (7) | (3) | 7 | (8) | (1) |
Loss on disposal of financial | ||||||
asset | – | 3 | 3 | – | 9 | 9 |
Recycling of cash flow hedge | ||||||
reserve | (2) | – | (2) | – | – | – |
Decrease/(increase) in | ||||||
inventories | (20) | 4 | (16) | (4) | – | (4) |
Decrease/(increase) in trade | ||||||
and other receivables | (35) | 35 | – | (107) | 26 | (81) |
Increase/(decrease) in trade | ||||||
and other payables | (5) | 7 | 2 | 71 | (21) | 50 |
Increase/(decrease) in | ||||||
provisions | 9 | (55) | (46) | 3 | (5) | (2) |
Cash generated from | ||||||
operations | 656 | (64) | 592 | 595 | (47) | 548 |
Interest paid | (63) | – | (63) | (57) | – | (57) |
Interest received | 40 | – | 40 | 26 | – | 26 |
Tax paid | (113) | – | (113) | (99) | – | (99) |
Net cash inflow from operating | ||||||
activities | 520 | (64) | 456 | 465 | (47) | 418 |
Year ended 31 July 2025 | Year ended 31 July 2024 | |||||
Headline | Non-headline | Total | Headline | Non-headline | Total | |
£m | £m | £m | £m | £m | £m | |
Net cash inflow from | ||||||
operating activities | 520 | (64) | 456 | 465 | (47) | 418 |
Include: | ||||||
Expenditure on capitalised | ||||||
development, other intangible | ||||||
assets and property, plant and | ||||||
equipment | (80) | – | (80) | (86) | – | (86) |
Repayment of lease liabilities | (41) | – | (41) | (39) | – | (39) |
Funding of charitable | ||||||
foundation | – | 1 | 1 | – | 1 | 1 |
Movement in cash collateral | – | – | – | 4 | – | 4 |
Free cash-flow | 336 | 298 | ||||
Exclude: | ||||||
Repayment of lease liabilities | 41 | – | 41 | 39 | – | 39 |
Interest paid | 63 | – | 63 | 57 | – | 57 |
Interest received | (40) | – | (40) | (26) | – | (26) |
Tax paid | 113 | – | 113 | 99 | – | 99 |
Funding of charitable | ||||||
foundation | – | (1) | (1) | – | (1) | (1) |
Movement in cash collateral | – | – | – | (4) | – | (4) |
Operating cash-flow | 576 | (64) | 512 | 509 | (47) | 462 |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Headline operating profit | 580 | 526 |
Headline operating cash-flow | 576 | 509 |
Headline operating cash conversion | 99% | 97% |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
£m | £m | |
Free cash-flow | 336 | 298 |
Disposal of financial assets | 53 | 186 |
Disposal of subsidiaries – post-sale expenses | (12) | – |
Acquisition of businesses | (121) | (65) |
Funding of charitable foundation | (1) | (1) |
Other net cash-flows used in financing activities | ||
(note: repayment of lease liabilities is included in free cash-flow) | (476) | (230) |
Net (decrease)/increase in cash and cash equivalents | (221) | 188 |
APM term | Definition and purpose |
Capital employed | Capital employed is a non-statutory measure of invested resources. |
It comprises statutory net assets and is adjusted as follows: | |
– To add goodwill recognised directly in reserves in respect of subsidiaries | |
acquired before 1 August 1998; | |
– To eliminate the Group's investment in ICU Medical, Inc. equity and | |
deferred consideration contingent on the future share price performance | |
of ICU Medical, Inc; and | |
– To eliminate post-retirement benefit assets and liabilities and non- | |
headline litigation provisions related to John Crane, Inc. and Titeflex | |
Corporation, both net of deferred tax, and net debt. | |
It is used to monitor capital allocation within the Group. See below for a | |
reconciliation from net assets to capital employed. | |
Capital expenditure | Comprises additions to property, plant and equipment, capitalised |
development and other intangible assets, excluding assets acquired | |
through business combinations: see note 1 for an analysis of capital | |
expenditure. This measure quantifies the level of capital investment into | |
ongoing operations. |
APM term | Definition and purpose |
Divisional headline | DHOP comprises divisional earnings before central costs, finance costs |
operating profit (DHOP) | and taxation. DHOP is used to monitor divisional performance. |
A reconciliation of DHOP to operating profit is shown in note 1. | |
Free cash-flow | Free cash-flow is calculated by adjusting the net cash inflow from |
operating activities to include capital expenditure, the repayment of lease | |
liabilities, the proceeds from the disposal of property, plant and equipment | |
and the investment in financial assets relating to operating activities and | |
pensions financing outstanding at the balance sheet date. The measure | |
shows cash generated by the Group before discretionary expenditure on | |
acquisitions and returns to shareholders. A reconciliation of free cash-flow | |
is shown in note 29. | |
Gross debt | Gross debt is total borrowings (bank, bonds and lease liabilities). It is used |
to provide an indication of the Group's overall level of indebtedness. See | |
note 18 for an analysis of gross debt. | |
Headline | The Group has defined a 'headline' measure of performance that excludes |
material non-recurring items or items considered non-operational/ | |
trading in nature. Items excluded from headline are referred to as non- | |
headline items. This measure is used by the Group to measure and monitor | |
performance excluding material non-recurring items or items considered | |
non-operational. See note 3 for an analysis of non-headline items. | |
Headline EBITDA | EBITDA is a widely used profit measure, not defined by IFRS, being |
earnings before interest, taxation, depreciation and amortisation. A | |
reconciliation of headline operating profit to headline EBITDA is shown in | |
the note below. | |
Net debt | Net debt is total borrowings (bank, bonds and lease liabilities) less cash |
balances and derivatives used to manage the interest rate risk and | |
currency profile of the debt. This measure is used to provide an indication | |
of the Group's overall level of indebtedness and is widely used by investors | |
and credit rating agencies. See note 18 for an analysis of net cash/(debt). | |
Non-headline | The Group has defined a 'headline' measure of performance that excludes |
material non-recurring items or items considered non-operational/trading | |
in nature. Items excluded from headline are referred to as non-headline | |
items. This is used by the Group to measure and monitor material non- | |
recurring items or items considered non-operational. See note 3 for an | |
analysis of non-headline items. |
APM term | Definition and purpose |
Operating cash-flow | Comprises free cash-flow and excludes cash-flows relating to the |
repayment of lease liabilities, interest and taxation. The measure shows | |
how cash is generated from operations in the Group. A reconciliation of | |
operating cash-flow is shown in note 29. | |
Operating profit | Operating profit is earnings before finance costs and tax. A reconciliation |
of operating profit to profit before tax is shown on the income statement | |
on page 119. This common measure is used by the Group to measure and | |
monitor performance. | |
Return on capital | Smiths ROCE is calculated over a rolling 12-month period and is the |
percentage that headline operating profit represents of the monthly | |
employed (ROCE) | |
average capital employed on a rolling 12-month basis. This measure of | |
return on invested resources is used to monitor performance and capital | |
allocation within the Group. See below for Group ROCE and note 1 for | |
divisional headline operating profit and divisional capital employed. |
KPI term | Definition and purpose | |
Dividend cover – | Dividend cover is the ratio of headline earnings per share (see note 5) to | |
headline | dividend per share (see note 25). This commonly used measure indicates | |
the number of times the dividend in a financial year is covered by headline | ||
earnings. | ||
Headline Earnings per | Headline EPS growth is the growth in headline basic EPS (see note 5), on | |
share (EPS) growth | a reported basis. Headline EPS growth is used to measure and monitor | |
performance. | ||
Free cash-flow (as a % of | This measure is defined as free cash-flow divided by headline operating | |
operating profit) | profit averaged over a three-year performance period. This cash | |
generation measure is used by the Group as a performance measure for | ||
remuneration purposes. | ||
Greenhouse gas (GHG) | GHG reduction is calculated as the percentage change in normalised | |
emissions reduction | Scope 1 & 2 GHG emissions. Normalised is calculated as tCO 2 e per £m of | |
revenue. This measure is used to monitor environmental performance. | ||
KPI term | Definition and purpose |
Gross vitality | Gross vitality is calculated as the percentage of revenue derived from new |
products and services launched in the last five years. This measure is used | |
to monitor the effectiveness of the Group's new product development and | |
commercialisation. | |
My Say engagement | The overall score in our My Say employee engagement survey. The |
score | biannual survey is undertaken Group-wide. This measure is used by the |
Group to monitor employee engagement. | |
Operating cash | Comprises headline operating cash-flow, excluding restructuring costs, |
conversion | as a percentage of headline operating profit. This measure is used to show |
the proportion of headline operating profit converted into cash-flow from | |
operations before investment, finance costs, non-headline items and | |
taxation. The calculation is shown in note 29. | |
Operating profit margin | Operating profit margin is calculated by dividing headline operating profit |
by revenue. This measure is used to monitor the Group’s ability to drive | |
profitable growth and control costs. | |
Organic growth | Organic growth adjusts the movement in headline performance to exclude |
the impact of foreign exchange and acquisitions. Organic growth is used by | |
the Group to aid comparability when monitoring performance. | |
Organic revenue growth | Organic revenue growth (remuneration) is compounded annualised growth |
(remuneration) | in revenue after excluding the impact of foreign exchange and acquisitions. |
The measure used for remuneration differs from organic revenue growth | |
in that it is calculated on a compounded annualised basis. This measure | |
has historically been used by the Group for aligning remuneration with | |
business performance. | |
Percentage of senior | Percentage of senior leadership positions taken by females is calculated |
leadership positions | as the percentage of senior leadership roles (G14+ group) held by females. |
taken by females | This measure is used by the Group to monitor diversity performance. |
RD&E cash costs as a % | This measure is defined as the cash cost of research, development, |
of sales | and customer-specific engineering activities (RD&E) as a percentage of |
revenue. | RD&E includes capitalised RD&E, RD&E directly charged to the |
P&L and customer-funded projects. Innovation is an important driver of | |
sustainable growth for the Group and this measures our investment in | |
research and development to drive innovation. | |
This KPI has replaced “R&D cash costs as a % of sales” as the Group’s | |
measure of research and development investment. |
KPI term | Definition and purpose |
Recordable Incident Rate | Recordable Incident Rate is calculated as the number of recordable |
(RIR) | incidents – where an incident requires medical attention beyond first aid |
– per 100 colleagues, per year across Smiths. This measure is used by the | |
Group to monitor health and safety performance. |
31 July 2025 | 31 July 2024 | ||
Notes | £m | £m | |
Net assets | 2,060 | 2,252 | |
Adjust for: | |||
Goodwill recognised directly in reserves | 478 | 478 | |
Retirement benefit assets and obligations | 8 | (32) | (29) |
Tax related to retirement benefit assets and obligations | 18 | 17 | |
John Crane, Inc. litigation provisions and related tax | 23 | 145 | 166 |
Titeflex Corporation litigation provisions and related tax | 23 | 20 | 27 |
Investment in ICU Medical, Inc. equity | 14 | – | (47) |
Net debt (includes £21m of net cash from discontinued | |||
operations) | 18 | 441 | 213 |
Capital employed | 3,130 | 3,077 |
Year ended | Year ended | ||
31 July 2025 | 31 July 2024 | ||
Notes | £m | £m | |
Headline operating profit for previous 12 months – including | |||
discontinued operations | 580 | 526 | |
Average capital employed – including discontinued operations | |||
(excluding investment in ICU Medical, Inc. equity) | 1 | 3,204 | 3,206 |
ROCE | 18.1% | 16.4% |
Year ended | Year ended | |
31 July 2025 | 31 July 2024 | |
Notes | £m | £m |
Revenue | ||
Continuing operations | 2,915 | 2,778 |
Discontinued operations | 421 | 354 |
Total Group | 3,336 | 3,132 |
Headline operating profit | ||
Continuing operations | 505 | 477 |
Discontinued operations | 75 | 49 |
Total Group | 580 | 526 |
Year ended | Year ended | ||
31 July 2025 | 31 July 2024 | ||
Notes | £m | £m | |
Headline operating profit – total Group | 580 | 526 | |
Exclude: | |||
– depreciation of property, plant and equipment | 29 | 43 | 44 |
– depreciation of right of use assets | 13 | 34 | 34 |
– amortisation and impairment of development costs | 10 | 10 | 2 |
– amortisation of software, patents and intellectual property | 10 | 15 | 5 |
Headline EBITDA | 682 | 611 |
Year ended | Year ended | ||
31 July 2025 | 31 July 2024 | ||
Notes | £m | £m | |
Headline EBITDA | 682 | 611 | |
Net debt (including £21m of net cash from discontinued | |||
operations) | 18 | 441 | 213 |
Ratio of net debt to headline EBITDA | 0.6 | 0.3 |
Year ended | ||
Year ended | 31 July 2024 | |
31 July 2025 | represented* | |
Notes | £m | £m |
Headline operating profit – continuing operations | 505 | 477 |
Exclude: | ||
– depreciation of property, plant and equipment | 36 | 37 |
– depreciation of right of use assets | 31 | 31 |
– amortisation and impairment of development costs | 10 | 2 |
– amortisation of software, patents and intellectual property | 14 | 3 |
Headline EBITDA | 596 | 550 |
Company name | Company number |
EIS Group Limited | 61407 |
Flexibox International Limited | 394688 |
Flex-Tek Group Limited | 11545405 |
Graseby Limited | 894638 |
SI Properties Limited | 160881 |
Smiths Detection Group Limited | 5138140 |
Smiths Detection Investments Limited | 5146644 |
Smiths Finance Limited | 7888063 |
Smiths Group Innovation Limited | 10953689 |
Smiths Interconnect Group Limited | 6641403 |
Smiths Pensions Limited | 2197444 |